Literature DB >> 4198108

Endocrine studies in anencephaly.

A Hayek, S G Driscoll, J B Warshaw.   

Abstract

Endocrine function has been investigated in four anencephalic neonates to determine the influence of absence of cortical and hypothalamic tissue and of hypoplasia of the pituitary. Intravenous glucose administration resulted in higher peak values for blood sugar and more rapid glucose disposal rates than reported in normals. Intravenous insulin tolerance tests on two of the infants failed to evoke elevations in plasma growth hormone, and the infants showed a remarkable resistance to the hypoglycemic effect of insulin. Administration of lysine-vasopressin caused an active growth hormone release. Similarly, there was a large increase in serum thyrotropin after administration of synthetic thyrotropin-releasing hormone. Basal levels of both thyrotropin and growth hormone were low as compared with values reported for normal newborns. Prolactin values obtained on three of the infants were in the normal range. The results strongly suggest that anterior pituitary function mediated by the hypothalamus and its releasing factors is deficient in anencephaly. However, the anterior pituitary can release growth hormone and thyrotropin when stimulated directly and, in the case of thyrotropin release, may function autonomously. The normal prolactin values presumably reflect the absence of the hypothalamic prolactin inhibitory factor.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4198108      PMCID: PMC302437          DOI: 10.1172/JCI107343

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve.

Authors:  N Fleischer; M Lorente; J Kirkland; R Kirkland; G Clayton; M Calderon
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

2.  Effect of vasopressin on serum-levels of human growth hormone.

Authors:  J J Gagliardino; J D Bailey; J M Martin
Journal:  Lancet       Date:  1967-06-24       Impact factor: 79.321

3.  Aqueous vasopressin provocative test of anterior pituitary function.

Authors:  R L Eddy
Journal:  J Clin Endocrinol Metab       Date:  1968-12       Impact factor: 5.958

4.  Autoregulation of growth hormone secretion in normal subjects.

Authors:  T C Hagen; A M Lawrence; L Kirsteins
Journal:  Metabolism       Date:  1972-07       Impact factor: 8.694

5.  Clinical evaluation of the determination of thyroxine iodine.

Authors:  C E Cassidy; J Benotti; S Peno
Journal:  J Clin Endocrinol Metab       Date:  1968-03       Impact factor: 5.958

6.  Recent advances in the double isotope derivative analysis of steroids.

Authors:  B Kliman
Journal:  Adv Tracer Methodol       Date:  1968

7.  Genetics of common disorders.

Authors:  C O Carter
Journal:  Br Med Bull       Date:  1969-01       Impact factor: 4.291

8.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation.

Authors:  K Sterling; M A Brenner
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

9.  Partial target organ resistance to thyroid hormone.

Authors:  H H Bode; M Danon; B D Weintraub; F Maloof; J D Crawford
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

View more
  9 in total

1.  The ontogenesis of human fetal hormones. III. Prolactin.

Authors:  M J Aubert; M M Grumbach; S L Kaplan
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Plasma prolactin and clinical outcome in preterm infants.

Authors:  A Lucas; B A Baker; T J Cole
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

3.  Neontal hypoglycaemia in infants of insulin-dependent diabetic mothers.

Authors:  F I Martin; G W Dahlenburg; J Russell; P Jeffery
Journal:  Arch Dis Child       Date:  1975-06       Impact factor: 3.791

4.  Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses.

Authors:  M Arosio; D Cortelazzi; L Persani; E Palmieri; G Casati; A M Baggiani; G Gambino; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

5.  Immunocytochemical study of the GH cells in the anterior pituitary gland of human fetus II. Anencephalic fetus.

Authors:  Toshiaki Tachibana; Takayasu Ito
Journal:  Hum Cell       Date:  2003-12       Impact factor: 4.174

6.  Effect of metoclopramide on maternal and fetal hyperprolactinemia.

Authors:  G Robuschi; R Emanuele; L d'Amato; M Salvi; E Dall'Aglio; E Gardini; M Fatone; S Foscolo; A Gnudi; E Roti
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

7.  Influence of bromocriptine on plasma levels of prolactin and steroid hormones in the 20th week of pregnancy.

Authors:  W D Lehmann; K Musch; A S Wolf
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

8.  Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications.

Authors:  M G Forest
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

9.  The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature.

Authors:  Octavian Munteanu; Monica Mihaela Cîrstoiu; Florin Mihail Filipoiu; Maria Narcisa Neamţu; Irina Stavarache; Tiberiu Augustin Georgescu; Ovidiu Gabriel Bratu; Gabriela Iorgulescu; Roxana Elena Bohîlţea
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.